Compounds for the treatment of hepatitis C

Details for Australian Patent Application No. 2008226639 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Kadow, John F.; Tu, Yong; Yeung, KapSun; Gentles, Robert G.; Hewawasam, Piyasena; Hudyma, Thomas W.; Ding, Min; Grant-Young, Katharine A.; Zheng, Xiaofan; Bender, John A.; Han, Ying

Agent A J Park

Pub. Number AU-B-2008226639

PCT Pub. Number WO2008/112473

Priority 60/894,887 14.03.07 US; 60/989,474 21.11.07 US

Filing date 5 March 2008

Wipo publication date 18 September 2008

Acceptance publication date 19 July 2012

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

17 September 2009 PCT application entered the National Phase

  PCT publication WO2008/112473 Priority application(s): WO2008/112473

19 July 2012 Application Accepted

  Published as AU-B-2008226639

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008226645-Salts of 3- (1H-ind0l-3-yl) -4- [2- (4methyl-piperazin-i-yl) -quinazolin-4-yl] - pyrrole-2, 5-di one

2008226638-Delay mechanism for automatic injection device